Treatments & Techniques
Observational studies have linked proton pump inhibitors (PPIs) to a litany of health conditions. A recent randomized controlled trial undermines many of those associations, finding PPIs to be largely safe to use for at least three years.
New research finds that following bariatric surgery, severely obese adolescents are more likely than their adult counterparts to experience complete remission of key comorbidities.
Volumetric multispectral optoacoustic tomography (MSOT) could foster accurate characterization of the makeup of arterial plaque in real time, according to scientists.
As NASA prepares to send astronauts to Mars sometime in the 2030s, scientists are using the concepts behind precision medicine to develop a way to predict and prevent medical conditions during space missions.
Radiologists transitioned from reading 2D mammograms to reading 3D mammograms rapidly and with enhanced accuracy, according to a study in Radiology.
Clinicians making the transition to 3D mammography, or digital breast tomosynthesis, needed...
The combined magnitude of innovation’s impact on medicine sometimes hides behind the patchwork of advances in different areas of healthcare technology.
Among the 35 percent of pancreatic cancer patients whose tumors have begun spreading into surrounding blood vessels and are often deemed inoperable, life-extending surgery may in fact be possible, according to a study published in Annals of Surgery.
In the final results of a major international clinical trial, women with hormone receptor-negative breast cancer who received a combination of standard chemotherapy and hormone treatment were more likely to become pregnant and enjoyed a better five-year survival rate than patients who received chemotherapy alone.
Research presented at a meeting of the Radiological Society of North America (RSNA) adds to existing evidence that women age 75 or older benefit from continued mammography screening, expanding the debate about whether the age recommendations for these screenings should change.
Significant numbers of women for whom hormone therapy (HT) poses little risk stopped undergoing or did not initiate HT based on misinterpretations of a 2002 announcement about safety concerns, new research finds.
The rate of...